Compounds > 1,1',3,3,3',3'-hexamethylindotricarbocyanine
Page last updated: 2024-12-11
1,1',3,3,3',3'-hexamethylindotricarbocyanine
1,1',3,3,3',3'-hexamethylindotricarbocyanine, commonly known as **HITC**, is a cyanine dye with a specific chemical structure:
* **Structure:** It has a trimethine chain (three carbon atoms connected by double bonds) with a positive charge at one end and a negative charge at the other.
* **Chromophore:** The trimethine chain acts as the chromophore, the part of the molecule responsible for absorbing and emitting light.
* **Substitution:** It has six methyl groups (CH3) attached to the indole rings.
**Importance in Research:**
HITC is an important dye for research, particularly in the following areas:
* **Fluorescent Microscopy:** HITC is a near-infrared (NIR) fluorescent dye. This means it absorbs and emits light in the near-infrared region of the electromagnetic spectrum.
* **Advantages:** NIR light penetrates biological tissues better than visible light, reducing scattering and allowing for deeper imaging.
* **Applications:** HITC is used for in vivo imaging, cell tracking, and studying biological processes in living organisms.
* **Optical Spectroscopy:** Its spectral properties make it useful for:
* **Fluorescence spectroscopy:** Studying the interactions of molecules in solution.
* **Absorption spectroscopy:** Measuring the concentration of specific molecules.
* **Bioconjugation:** HITC can be modified to attach to biomolecules like antibodies, proteins, or peptides.
* **Applications:** Used for labelling specific targets in cells or tissues, enabling targeted fluorescence imaging.
**In addition to its specific uses, HITC is also valued for:**
* **High quantum yield:** It efficiently emits light upon excitation, making it bright for fluorescence imaging.
* **High photostability:** It is resistant to photobleaching, allowing for extended imaging without signal loss.
* **Water solubility:** It is easily soluble in water, making it suitable for biological studies.
**Overall, HITC is a versatile tool for researchers working in various fields such as biology, chemistry, and medicine.**
Cross-References
ID Source | ID |
PubMed CID | 5702731 |
MeSH ID | M0151015 |
Synonyms (11)
Synonym |
1,3,3-trimethyl-2-(7-(1,3,3-trimethylindol-2-ylidene)-1,3,5-heptatrienyl)indolium perchlorate |
AKOS000813917 |
16595-48-5 |
einecs 240-652-5 |
1,1',3,3,3',3'-hexamethylindotricarbocyanine |
3h-indolium, 2-(7-(1,3-dihydro-1,3,3-trimethyl-2h-indol-2-ylidene)-1,3,5-heptatrienyl)-1,3,3-trimethyl-, perchlorate |
3h-indolium, 2-(7-(1,3-dihydro-1,3,3-trimethyl-2h-indol-2-ylidene)-1,3,5-heptatrien-1-yl)-1,3,3-trimethyl-, perchlorate (1:1) |
2-(7-(1,3-dihydro-1,3,3-trimethyl-2h-indol-2-ylidene)hepta-1,3,5-trienyl)-1,3,3-trimethyl-3h-indolium perchlorate |
3h-indolium, 2-[7-(1,3-dihydro-1,3,3-trimethyl-2h-indol-2-ylidene)-1,3,5-heptatrienyl]-1,3,3-trimethyl-, perchlorate |
hitc perchlorate |
CS-0435239 |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.59
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.59 (24.57) | Research Supply Index | 2.08 (2.92) | Research Growth Index | 4.66 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |